SpringWorks Therapeutics Inc
SWTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.54B
Close$
$-38.60
182.1% downside
Current Fair Value
182.1% downsideOvervalued by 182.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.54 Billion |
|---|---|
| Enterprise Value | $3.50 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.48 |
| Beta | 0.7 |
| Outstanding Shares | 74,885,348 |
Return
| Return on Equity | -60.84% |
|---|---|
| Return on Assets | -50.25% |
| Return on Invested Capital | -62.57% |
Valuation & Multiples
| P/E Ratio | -13.5 |
|---|---|
| PEG | 281.07 |
| Price to Sales | 23.5 |
| Price to Book Ratio | 9.4 |
| Enterprise Value to Revenue | 15.93 |
| Enterprise Value to EBIT | -13.22 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0895▼ 35.07% |
|---|---|
| Total Calls | 9,323,649▲ 61.25% |
| Total Puts | 834,300▼ 67.22% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 100.34%▲ 1.92% |
|---|---|
| Total Invested | $3.53B▲ 8.48% |
| Investors Holding | 248▼ 103.00% |
ESG Score
No data